功能性RBMY1拷贝数变异与精子活力相关:无精子因子区域与弱精子症相关的候选基因
研究纳入2009至2016年3127名成年男性,在1070名无染色体异常或已知AZF结构突变的Y染色体单倍群O3*或O3e携带者中分析功能性RBMY1拷贝数与精子表型的关联。发现RBMY1功能性拷贝剂量与精子活力正相关,拷贝数不足是弱精子症的独立危险因素。
要点
- RBMY1功能性拷贝剂量与精子活力正相关。
- RBMY1拷贝数少于6的男性相对6拷贝者弱精子症风险升高。
- RBMY1拷贝剂量与睾丸中mRNA及蛋白水平正相关。
核心结论
- RBMY1功能性拷贝剂量与精子活力正相关,剂量不足是弱精子症的独立危险因素。
- RBMY1通过调控精子活力影响男性对弱精子症的易感性。
研究设计与样本
- 2009至2016年招募3127名成年男性,其中486名可育男性用于研究RBMY1功能性拷贝剂量。
- 在2641名已知精子生成状态的男性中筛选1070名Y染色体单倍群O3*或O3e携带者,包括506名精液正常者和564名少精子症和/或弱精子症者。
- 在15份睾丸组织和8份精液样本中分析RBMY1剂量与mRNA/蛋白水平及精子RBMY1水平与活力的相关性,另用10份精液样本确认RBMY1亚细胞定位。
主要发现
- 在入组人群中识别出Y染色体单倍群无关的功能性RBMY1拷贝数变异。
- 正常精子活力组与弱精子症组之间RBMY1拷贝数分布存在差异。
- RBMY1拷贝数少于6的男性相对6拷贝者(人群最常见剂量)弱精子症风险升高。
- RBMY1拷贝剂量与睾丸中mRNA及蛋白水平正相关。
- 高活力精子携带的RBMY1蛋白多于活力相对较低的精子,RBMY1蛋白主要定位于精子颈部和中部以及精子尾部主段。
临床怎么用
- 作者认为RBMY1拷贝数分析在弱精子症所致男性不育的临床咨询中具有意义。
- 原文未据此给出具体临床推荐。
局限性
- RBMY1功能性拷贝与大量假基因间序列高度相似,可能降低拷贝数检测准确性。
- RBMY1拷贝数变异的机制尚不清楚。
- 不能排除RBMY1拷贝簇结构变异对该区域其他蛋白编码基因拷贝剂量的影响,可能使观察结果产生偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the influence of copy number variation (CNV) in functional RNA binding motif protein Y-linked family 1 (RBMY1) on spermatogenic phenotypes? SUMMARY ANSWER: The RBMY1 functional copy dosage is positively correlated with sperm motility, and dosage insufficiency is an independent risk factor for asthenozoospermia. WHAT IS KNOWN ALREADY: RBMY1, a multi-copy gene expressed exclusively in the adult testis, is one of the most important candidates for male infertility in the azoospermia factor (AZF) region of the Y-chromosome. RBMY1 encodes an RNA-binding protein that serves as a pre-mRNA splicing regulator during spermatogenesis, and male mice deficient in Rbmy are sterile. STUDY DESIGN, SIZE, DURATION: A total of 3127 adult males were recruited from 2009 to 2016; of this group, the dosage of RBMY1 functional copy were investigated in 486 fertile males. In the remaining 2641 males with known spermatogenesis status, 1070 Y-chromosome haplogroup (Y-hg) O3* or O3e carriers without chromosomal aberration or known AZF structure mutations responsible for spermatogenic impairment, including 506 men with normozoospermia and 564 men with oligozoospermia or/and asthenozoospermia, were screened, and the RBMY1 functional copy dosage and copy conversion were determined to explore their associations with sperm phenotypes. The correlation between RBMY1 dosage and its mRNA level or RBMY1 protein level and the correlation between sperm RBMY1 level and motility were analysed in 15 testis tissue samples and eight semen samples. Ten additional semen samples were used to confirm the subcellular localization of RBMY1 in individual sperm. PARTICIPANTS/MATERIALS, SETTING, METHODS: All the Han volunteers donating whole blood, semen and testis tissue were from southwest China. RBMY1 copy number, copy conversion, mRNA/protein amount and protein location in sperm were detected using the AccuCopy® assay method, paralog ratio test, quantitative PCR, western blotting and immunofluorescence staining methods, respectively. MAIN RESULTS AND THE ROLE OF CHANCE: This study identified Y-hg-independent CNV of functional RBMY1 in the enrolled population. A difference in the distribution of RBMY1 copy number was observed between the group with normal sperm motility and the group with asthenozoospermia. A positive correlation between the RBMY1 copy dosage and sperm motility was identified, and the males with fewer than six copies of RBMY1 showed an elevated risk for asthenozoospermia relative to those with six RBMY1 copies, the most common dosage in the population. The RBMY1 copy dosage was positively correlated with its mRNA and protein level in the testis. Sperm with high motility were found to carry more RBMY1 protein than those with relatively low motility. The RBMY1 protein was confirmed to predominantly localize in the neck and mid-piece region of sperm as well as the principal piece of the sperm tail. Our population study completes a chain of evidence suggesting that RBMY1 influences the susceptibility of males to asthenozoospermia by modulating sperm motility. LIMITATIONS REASONS FOR CAUTION: High sequence similarity between the RBMY1 functional copies and a large number of pseudogenes potentially reduces the accuracy of the copy number detection. The mechanism underlying the CNV in RBMY1 is still unclear, and the effect of the structural variations in the RBMY1 copy cluster on the copy dosage of other protein-coding genes located in the region cannot be excluded, which may potentially bias our observations. WIDER IMPLICATIONS OF THE FINDINGS: Asthenozoospermia is a multi-factor complex disease with a limited number of proven susceptibility genes. This study identified a novel genomic candidate independently contributing to the condition, enriching our understanding of the role of AZF-linked genes in male reproduction. Our finding provides insight into the physiological and pathological characteristics of RBMY1 in terms of sperm motility, supplies persuasive evidence of the significance of RBMY1 copy number analysis in the clinical counselling of male infertility resulting from asthenozoospermia. STUDY FUNDING/COMPETING INTEREST(S): This work was funded by the National Natural Science Foundation of China (Nos. 81370748 and 30971598). The authors have no conflicts of interest.
引用
- Yan Y, Yang X, Liu Y, et al. Copy number variation of functional RBMY1 is associated with sperm motility: an azoospermia factor-linked candidate for asthenozoospermia. Hum Reprod. 2017. PMID: 28498920. doi:10.1093/humrep/dex100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。